These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22530896)

  • 1. A quantitative structure-activity relationship study on a few series of anti-hepatitis C virus agents.
    Varshney J; Sharma A; Gupta SP
    Med Chem; 2012 May; 8(3):491-504. PubMed ID: 22530896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 3D-QSAR study on a series of benzimidazole derivatives acting as hepatitis C virus inhibitors: application of kNN-molecular field analysis.
    Gupta SP; Samanta S; Patil VM
    Med Chem; 2010 Mar; 6(2):87-90. PubMed ID: 20218964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Hepatitis C Replication by Targeting the Molecular Chaperone Hsp90: Synthesis and Biological Evaluation of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazole Derivatives.
    Lillsunde KE; Tomašič T; Schult P; Lohmann V; Kikelj D; Tammela P
    ChemMedChem; 2019 Feb; 14(3):334-342. PubMed ID: 30548820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antiviral activity of some new bis-1,3-thiazole derivatives.
    Dawood KM; Eldebss TM; El-Zahabi HS; Yousef MH
    Eur J Med Chem; 2015 Sep; 102():266-76. PubMed ID: 26291036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereo-controlled synthesis of functionalized tetrahydropyridines based on the cyanomethylation of 1,6-dihydropyridines and generation of anti-hepatitis C virus agents.
    Watanabe R; Mizoguchi H; Oikawa H; Ohashi H; Watashi K; Oguri H
    Bioorg Med Chem; 2017 Jun; 25(11):2851-2855. PubMed ID: 28314509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 2-iminobenzimidazoles as potent hepatitis C virus inhibitors with a novel mechanism of action.
    Windisch MP; Jo S; Kim HY; Kim SH; Kim K; Kong S; Jeong H; Ahn S; No Z; Hwang JY
    Eur J Med Chem; 2014 May; 78():35-42. PubMed ID: 24675178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and SAR of pyridothiazole substituted pyrimidine derived HCV replication inhibitors.
    Girijavallabhan VM; Alvarez C; Bennett F; Chen L; Gavalas S; Huang Y; Kim SH; Kosinski A; Pinto P; Rizvi R; Rossman R; Shankar B; Tong L; Velazquez F; Venkatraman S; Verma VA; Kozlowski J; Shih NY; Piwinski JJ; MacCoss M; Kwong CD; Bansal N; Clark JL; Fowler AT; Kezar HS; Valiyaveettil J; Reynolds RC; Maddry JA; Ananthan S; Secrist JA; Li C; Chase R; Curry S; Huang HC; Tong X; Njoroge FG; Arasappan A
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5652-7. PubMed ID: 22858143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A QSAR study on a series of thiourea derivatives acting as anti-hepatitis C virus agents.
    Sharma A; Gupta SP; Siddiqui AA
    Indian J Biochem Biophys; 2013 Aug; 50(4):278-83. PubMed ID: 24772946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazolides as novel antiviral agents. 2. Inhibition of hepatitis C virus replication.
    Stachulski AV; Pidathala C; Row EC; Sharma R; Berry NG; Lawrenson AS; Moores SL; Iqbal M; Bentley J; Allman SA; Edwards G; Helm A; Hellier J; Korba BE; Semple JE; Rossignol JF
    J Med Chem; 2011 Dec; 54(24):8670-80. PubMed ID: 22059983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity studies of (-)-epigallocatechin gallate derivatives as HCV entry inhibitors.
    Bhat R; Adam AT; Lee JJ; Deloison G; Rouillé Y; Séron K; Rotella DP
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4162-5. PubMed ID: 25103601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective synthesis and biological evaluation as inhibitors of hepatitis C virus RNA polymerase of GSK3082 analogues with structural diversity at the 5-position.
    Gálvez JA; Clavería-Gimeno R; Galano-Frutos JJ; Sancho J; Velázquez-Campoy A; Abian O; Díaz-de-Villegas MD
    Eur J Med Chem; 2019 Jun; 171():401-419. PubMed ID: 30928711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiviral evaluation of a novel series of homoserine-based inhibitors of the hepatitis C virus NS3/4A serine protease.
    Alexandre FR; Brandt G; Caillet C; Chaves D; Convard T; Derock M; Gloux D; Griffon Y; Lallos L; Leroy F; Liuzzi M; Loi AG; Moulat L; Musiu C; Parsy C; Rahali H; Roques V; Seifer M; Standring D; Surleraux D
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3984-91. PubMed ID: 26231161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and hepatitis C antiviral activity of 1-aminobenzyl-1H-indazole-3-carboxamide analogues.
    Shi JJ; Ji FH; He PL; Yang YX; Tang W; Zuo JP; Li YC
    ChemMedChem; 2013 May; 8(5):722-5. PubMed ID: 23512654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design and synthesis of 2,2-bisheterocycle tandem derivatives as non-nucleoside hepatitis B virus inhibitors.
    Chen HJ; Wang WL; Wang GF; Shi LP; Gu M; Ren YD; Hou LF; He PL; Zhu FH; Zhong XG; Tang W; Zuo JP; Nan FJ
    ChemMedChem; 2008 Sep; 3(9):1316-21. PubMed ID: 18663717
    [No Abstract]   [Full Text] [Related]  

  • 15. Thiazolidone derivatives as inhibitors of chikungunya virus.
    Jadav SS; Sinha BN; Hilgenfeld R; Pastorino B; de Lamballerie X; Jayaprakash V
    Eur J Med Chem; 2015 Jan; 89():172-8. PubMed ID: 25462237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and structure-activity relationship study of iminodipyridinopyrimidines as novel hepatitis C virus inhibitor.
    Park DS; Jo E; Choi J; Lee M; Kim S; Kim HY; Nam J; Ahn S; Hwang JY; Windisch MP
    Eur J Med Chem; 2017 Nov; 140():65-73. PubMed ID: 28923387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
    Johansson PO; Bäck M; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
    Bioorg Med Chem; 2006 Aug; 14(15):5136-51. PubMed ID: 16675222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and characterization of a novel 7-aminopyrazolo[1,5-a]pyrimidine analog as a potent hepatitis C virus inhibitor.
    Hwang JY; Windisch MP; Jo S; Kim K; Kong S; Kim HC; Kim S; Kim H; Lee ME; Kim Y; Choi J; Park DS; Park E; Kwon J; Nam J; Ahn S; Cechetto J; Kim J; Liuzzi M; No Z; Lee J
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7297-301. PubMed ID: 23159569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel thioglycosyl analogs of glycosyltransferase substrates as antiviral compounds against classical swine fever virus and hepatitis C virus.
    Pastuch-Gawolek G; Chaubey B; Szewczyk B; Krol E
    Eur J Med Chem; 2017 Sep; 137():247-262. PubMed ID: 28601004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and inhibitory activity on hepatitis C virus RNA replication of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl)aniline analogs.
    Matsuno K; Ueda Y; Fukuda M; Onoda K; Waki M; Ikeda M; Kato N; Miyachi H
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4276-80. PubMed ID: 25086684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.